🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
This phase II trial studies how well docetaxel or abiraterone acetate work ...
Status
Terminated
Location
Huntsman Cancer Institute/University of Utah
Start Date
2019-02-08
Trial ID
NCT03827473
This multicenter, international, Phase Ib/II trial consists of three stages...
Status
Completed
Location
HonorHealth Research Institute ? Bisgrove
Start Date
2012-01-11
Trial ID
NCT01485861
Treatments Being Tested
This study is for patients with cancer of the prostate gland that has metas...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2006-07
Trial ID
NCT00327340
Treatments Being Tested
The primary objective of this study was to determine the safety and Maximum...
Status
Completed
Location
Multiple Locations
Start Date
2005-11-01
Trial ID
NCT02182219
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of irofulven...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00124566
Treatments Being Tested
Azacitidine can reverse clinical resistance to docetaxel through upregulati...
Status
Terminated
Location
University of Miami Sylvester Comprehensive Cancer Center
Start Date
2007-05
Trial ID
NCT00503984
RATIONALE: Drugs used in chemotherapy, such as docetaxel and prednisone, wo...
Status
Terminated
Location
Chao Comprehensive Cancer Center
Start Date
2009-07
Trial ID
NCT00879619
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Northeast Georgia Medical Center
Start Date
2002-04
Trial ID
NCT00024167
This phase II trial studies how well the combination of apalutamide, abirat...
Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Start Date
2020-05-11
Trial ID
NCT04267887